Search

Author/Creator Ogiwara, Haru

2. Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice. Issue 1 (29th January 2019)

Authors:
Chen, Chang-Yu; Ueha, Satoshi; Ishiwata, Yoshiro; Yokochi, Shoji; Yang, De; Oppenheim, Joost J.; Ogiwara, Haru; Shichino, Shigeyuki; Deshimaru, Shungo; Shand, Francis H. W.; Shibayama, Shiro; Matsushima, Kouji
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. Issue 1 (24th July 2019)

Authors:
Shitara, Kohei; Ueha, Satoshi; Shichino, Shigeyuki; Aoki, Hiroyasu; Ogiwara, Haru; Nakatsura, Tetsuya; Suzuki, Toshihiro; Shimomura, Manami; Yoshikawa, Toshiaki; Shoda, Kayoko; Kitano, Shigehisa; Yamashita, Makiko; Nakayama, Takayuki; Sato, Akihiro; Kuroda, Sakiko; Wakabayashi, Masashi; Nomura, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search